Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 161-168

Bentham Science Publishers

Access to resources Recommend Favorite

Towards More Successful Gene Therapy Clinical Trials for &bgr;-Thalassemia

By  

Current Molecular Medicine, Vol. 13, Iss. 8, 2013-09 ,pp. : 1314-1330

Bentham Science Publishers

Access to resources Recommend Favorite

Association of &bgr;-tubulin, F-box/Leucine-Rich Repeat Protein 14, and Type 1 Procollagen C-peptide in Bovine Periosteal Cells

By  

Current Tissue Engineering, Vol. 3, Iss. 1, 2014-03 ,pp. : 2-6

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha Fetoprotein is More than a Hepatocellular Cancer Biomarker: From Spontaneous Immune Response in Cancer Patients to the Development of an AFP-Based Cancer Vaccine

By  

Current Molecular Medicine, Vol. 11, Iss. 7, 2011-10 ,pp. : 564-581

Bentham Science Publishers

Access to resources Recommend Favorite

Blockade of CD4 is more tolerogenic than blockade of Ag presentation via self MHC class II antigens

By Chen Z.K.   Frick T.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2000-2000

Elsevier

Access to resources Recommend Favorite